Mid-Term Outcomes in Patients Implanted with Cardiac Resynchronization Therapy.
10.3346/jkms.2014.29.12.1651
- Author:
Sung Ho LEE
1
;
Seung Jung PARK
;
June Soo KIM
;
Dae Hee SHIN
;
Dae Kyoung CHO
;
Young Keun ON
Author Information
1. Division of Cardiology, Kangbuk Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Publication Type:Original Article ; Clinical Trial
- Keywords:
Cardiac Resynchronization Therapy;
Echocardiography;
Heart Failure
- MeSH:
Age Distribution;
Cardiac Resynchronization Therapy/*mortality;
Cardiac Resynchronization Therapy Devices/*statistics & numerical data;
Female;
Heart Failure/diagnosis/*mortality/*prevention & control;
*Hospital Mortality;
Hospitalization/*statistics & numerical data;
Humans;
Longitudinal Studies;
Male;
Middle Aged;
Prevalence;
Prostheses and Implants/statistics & numerical data;
Recurrence;
Republic of Korea/epidemiology;
Risk Factors;
Sex Distribution;
Survival Rate;
Treatment Outcome
- From:Journal of Korean Medical Science
2014;29(12):1651-1657
- CountryRepublic of Korea
- Language:English
-
Abstract:
We applied cardiac resynchronization therapy (CRT) for desynchronized heart failure patients. We evaluated clinical outcomes including morbidity, mortality, and echocardiographic parameters in 47 patients with implanted CRT in Korea from October 2005 to May 2013. The combined outcomes of hospitalization from heart failure, heart transplantation and death were the primary end point. Median follow-up period was 17.5 months. The primary outcomes listed above occurred in 10 (21.3%) patients. Two patients (4.3%) died after CRT and 8 (17%) patients were hospitalized for recurrent heart failure. Among patients hospitalized for heart failure, 2 (4.3%) patients underwent heart transplantation. The overall free rate of heart failure requiring hospitalization was 90.1% (95% CI, 0.81-0.99) over one year and 69.4% (95% CI, 0.47-0.91) over 3 yr. We observed improvement of the New York Heart Association classification (3.1+/-0.5 to 1.7+/-0.4), decreases in QRS duration (169.1 to 146.9 ms), decreases in left ventricular (LV) end-diastolic (255.0 to 220.1 mL) and end-systolic (194.4 to 159.4 mL) volume and increases in LV ejection fraction (22.5% to 31.1%) at 6 months after CRT. CRT improved symptoms and echocardiographic parameters in a relatively short period, resulting in low mortality and a decrease in hospitalization due to heart failure.
